Dr David Britton

Postdoctoral Researcher
Research Focus

I am experienced in LC-MS/MS proteomics to identify and quantify proteins and their post-translational modifications in pre-clinical samples (cancer cells in culture, xenografts) and clinical biopsies (serum, plasma, blood cells, tissue), with the aim of identifying prognostic and diagnostic markers, as well as drug targets and therefore predictive markers for personalised medicine.

Such proteins may be enzymatic or structural and involved in mechanisms such as cell replication, survival, death, migration, invasion, metabolism, DNA repair, intracellular signalling, epigenetics, transcription and molecular transport.

My project is focussed on determining how these proteins enable acute myeloid leukaemia blasts to acquire or have intrinsic resistance to chemotherapy, with the aim to identify suitable pharmaceutical alternatives to combat resistance.

Dr Pedro R. Cutillas
Upcoming Events
  1. Thursday Seminar Series – Dr Benjamin Werner

    November 21 @ 12:30 pm - 1:30 pm
  2. Miltenyi Biotec Exhibition – Friday 22nd November 2019

    November 22 @ 9:00 am - 1:00 pm
© 2013 ~ 2019 Cancer Research UK Barts Centre